Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Clobazam

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,250Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of January 22, 2025
    Enforcement Report - Week of January 22, 2025

    22 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-22-2025-57502.pdf

    FDA
    22 Jan 2025
    Share Share
    Enforcement Report - Week of January 15, 2025
    Enforcement Report - Week of January 15, 2025

    15 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-15-2025-7287.pdf

    FDA
    15 Jan 2025
    Share Share
    Enforcement Report - Week of February 28, 2024
    Enforcement Report - Week of February 28, 2024

    28 Feb 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2024-59068.pdf

    FDA
    28 Feb 2024
    Share Share
    Assertio Provides Educational Grant for New LGS Foundation Treatments Kits
    Assertio Provides Educational Grant for New LGS Foundation Treatments Kits

    24 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/24/2652743/0/en/Assertio-Provides-Educational-Grant-for-New-Lennox-Gastaut-Syndrome-LGS-Foundation-Treatments-Kits.html

    GLOBENEWSWIRE
    24 Apr 2023
    Share Share
    Aquestive offloads film formulation seizure drug to Assertio
    Aquestive offloads film formulation seizure drug to Assertio

    31 Oct 2022

    // Nick Paul Taylor FIERCEPHARMA

    https://www.fiercepharma.com/pharma/aquestive-offloads-film-formulation-seizure-drug-assertio-securing-cash-epinephrine-rd

    Nick Paul Taylor FIERCEPHARMA
    31 Oct 2022
    Share Share
    Aquestive Therapeutics Licenses Sympazan Oral Film to Assertio Holdings, Inc.
    Aquestive Therapeutics Licenses Sympazan Oral Film to Assertio Holdings, Inc.

    27 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/27/2542933/0/en/Aquestive-Therapeutics-Licenses-Sympazan-clobazam-Oral-Film-to-Assertio-Holdings-Inc.html

    GLOBENEWSWIRE
    27 Oct 2022
    Share Share